[
    [
        {
            "time": "2021-02-18",
            "original_text": "上交所：自2月18日起，将康希诺、君实生物等纳入上证沪股通指数样本",
            "features": {
                "keywords": [
                    "上交所",
                    "康希诺",
                    "君实生物",
                    "上证沪股通指数",
                    "纳入样本"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "上交所：自2月18日起，将康希诺、君实生物等纳入上证沪股通指数样本",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]